Det anven - des som tillægsbehandling til anden astmamedicin hos voksne og unge over 12 år, når patienterne: • har haft en positiv lappeprøve for et allergen (et stof, der medfører allergi, dvs. overfølsomhed) i luften, f. eks. husstøvmider, pollen eller skimmel, • har nedsat lungefunktion (mindre end 80% af den normale) foruden hyppige symptomer i dag - tiden eller opvågninger om natten, og • har haft mange svære forværringer af deres astma (som kræver akut behandling med anden me - dicin), selv om de er i behandling med høje doser af inhalationskortikosteroider plus en lang - tidsvirkende inhaleret beta2- agonist.
It is used as an add-on to existing asthma treatment in adults and adolescents over the age of 12 years, who must: • have had a positive skin test result for an allergy caused by an allergen (a stimulus that causes an allergy) in the air, such as house dust mites, pollen or mould, • have reduced lung function (less than 80% of normal), as well as frequent symptoms during the day or waking up during the night, and, • have had many severe ‘ exacerbations ’ of asthma (where asthma got worse, requiring rescue treatment with other medicines) despite treatment with high doses of inhaled corticosteroids plus a long-acting inhaled beta2-agonist.